Literature DB >> 11377346

C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris.

O Bazzino1, E R Ferreirós, R Pizarro, G Corrado.   

Abstract

We assessed the 90-day prognostic value of stress tests and C-reactive protein (CRP) after medical stabilization of unstable angina. We included 139 consecutive patients with unstable angina who were free of complications or did not undergo revascularization during hospitalization. Blinded CRP assays and a stress test (95 exercise electrocardiograms, 44 dobutamine echocardiograms) were performed within the first week after discharge. Of 139 participants, 44 (31.6%) had an ischemic stress test response. CRP was elevated (> 1.5 mg/dl) in 40 patients (28.7%). CRP >1.5 mg/dl was more frequently observed among patients who experienced death or myocardial infarction at 90 days (88.2% vs 20.5%, p <0.0001). Compared with the stress tests, CRP showed greater sensitivity (88% vs 47%) and specificity (81% vs 70%) for increased risk, and higher positive (37.5% vs 18.2%) and negative (98% vs 90%) predictive values. The area under the receiver operating curve of the relation with the 90-day outcome increased from 0.58 +/- 0.07 to 0.83 +/- 0.05 when the CRP data were added to the stress tests results (p <0.001). Elevation of CRP differentiated stress tests negative patients with increased risk of major events during follow-up. In patients who respond to medical treatment for unstable angina, CRP elevation may be a better parameter than the stress test in identifying the presence of persistent plaque instability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377346     DOI: 10.1016/s0002-9149(01)01511-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.

Authors:  Mary S Beattie; Michael G Shlipak; Haiying Liu; Warren S Browner; Nelson B Schiller; Mary A Whooley
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

2.  Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.

Authors:  Vincenzo Panichi; Alessia Scatena; Massimiliano Migliori; Valentina Marchetti; Sabrina Paoletti; Sara Beati
Journal:  Int J Inflam       Date:  2012-06-04

Review 3.  Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease.

Authors:  Raed Osman; Philippe L L'Allier; Nader Elgharib; Jean-Claude Tardif
Journal:  Vasc Health Risk Manag       Date:  2006

4.  A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing.

Authors:  Jeffrey D McBride; Matthew A Cooper
Journal:  J Nanobiotechnology       Date:  2008-04-29       Impact factor: 10.435

5.  Serum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness.

Authors:  Bernard Panaszek; Ewa Liebhart; Jerzy Liebhart; Robert Pawłowicz; Andrzej M Fal
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.